Next, we investigated the potential mechanisms by which HSA-Trx suppresses the progression of NASH pathology, particularly its effect on oxidative stress, inflammation, and apoptosis. The gene discussed is TXN; the disease is metabolic dysfunction-associated steatohepatitis.